TBEV-ELISA | TBEV-VNT | WNV-ELISA | WNV-VNT | |||
---|---|---|---|---|---|---|
Sample | U/l 1 | Result | ND 50 | S/N% | Result | ND 50 |
Serum 1 | -2,995 | Negative | n.d. | 92,25% | Negative | < 1:10 |
Serum 2 | 12,500 | Borderline | >1:640/1:960 | 11,99% | Positive | < 1:10 |
Serum 3 | -2,938 | Negative | n.d. | 88,04% | Negative | < 1:10 |
Serum 4 | -3,802 | Negative | n.d. | 94,11% | Negative | < 1:10 |
Serum 5 | 3,859 | Negative | n.d. | 41,48% | Borderline | < 1:10 |
Serum 6 | 17,627 | Positive | 1:80 | 7,27% | Positive | < 1:10 |
Serum 7 | -2,650 | Negative | n.d. | 77,31% | Negative | < 1:10 |
Serum 8 | -3,571 | Negative | n.d. | 86,93% | Negative | < 1:10 |
Serum 9 | -3,168 | Negative | n.d. | 90,48% | Negative | < 1:10 |
Serum 10 | 3,111 | Negative | n.d. | 3,16% | Negative | < 1:10 |
Serum 11 | -0,806 | Negative | n.d. | 93,43% | Negative | < 1:10 |
Serum 12 | -3,975 | Negative | n.d. | 93,54% | Negative | < 1:10 |
Serum 13 | -2,995 | Negative | n.d. | 92,59% | Negative | < 1:10 |
Serum 14 | -3,744 | Negative | n.d. | 89,52% | Negative | < 1:10 |
Serum 15 | -2,995 | Negative | n.d. | 88,38% | Negative | < 1:10 |
Serum 16 | 4,896 | Negative | n.d. | 86,58% | Negative | < 1:10 |
Serum 17 | -3,168 | Negative | n.d. | 85,80% | Negative | < 1:10 |
Serum 18 | -2,765 | Negative | n.d. | 91,29% | Negative | < 1:10 |
Serum 19 | 17,915 | Positive | 1:80 | 15,04% | Positive | < 1:10 |
Serum 20 | 20,392 | Positive | 1:240 | 51,14% | Negative | < 1:10 |
Serum 21 | 12,212 | Borderline | 1:160 | 13,51% | Positive | < 1:10 |
Serum 22 | 17,569 | Positive | 1:320 | 9,48% | Positive | < 1:10 |
Serum 23 | -3,053 | Negative | n.d. | 84,21% | Negative | < 1:10 |
Serum 24 | -3,399 | Negative | n.d. | 83,57% | Negative | < 1:10 |
Serum 25 | 16,993 | Positive | 1:80 | 7,06% | Positive | < 1:10 |
Serum 26 | -4,818 | Negative | n.d. | 89,77% | Negative | < 1:10 |
Serum 27 | -5,867 | Negative | n.d. | 83,66% | Negative | < 1:10 |
Serum 28 | -3,959 | Negative | n.d. | 84,43% | Negative | < 1:10 |
Serum 29 | -5,295 | Negative | n.d. | 91,08% | Negative | < 1:10 |
Serum 30 | 10,351 | Borderline | <1:5 | 86,85% | Negative | < 1:10 |
Serum 31 | -5,200 | Negative | n.d. | 86,23% | Negative | < 1:10 |
Serum 32 | -4,532 | Negative | n.d. | 86,37% | Negative | < 1:10 |
Serum 33 | 31,245 | Positive | >1:40/1:720 | 27,45% | Positive | < 1:10 |
Serum 34 | 14,168 | Positive | >1:40/1:480 | 76,10% | Negative | < 1:10 |
Serum 35 | 21,991 | Positive | 1:40 | 40,69% | Borderline | < 1:10 |
Serum 36 | 35,443 | Positive | >1:40/>1:960 | 21,43% | Positive | < 1:10 |
Serum 37 | -5,581 | Negative | n.d. | 86,84% | Negative | < 1:10 |
Serum 38 | -4,913 | Negative | <1:5 | 88,36% | Negative | < 1:10 |
Serum 39 | 35,538 | Positive | >1:40/1:480 | 6,68% | Positive | < 1:10 |
Serum 40 | 30,291 | Positive | >1:40/1:960 | 17,62% | Positive | < 1:10 |
Serum 41 | -5,200 | Negative | <1:5 | 85,33% | Negative | < 1:10 |
Serum 42 | -3,864 | Negative | n.d. | 86,76% | Negative | < 1:10 |
Serum 43 | -5,486 | Negative | n.d. | 87,18% | Negative | < 1:10 |
Serum 44 | -3,959 | Negative | n.d. | 87,91% | Negative | < 1:10 |
Serum 45 | -5,200 | Negative | n.d. | 86,37% | Negative | < 1:10 |
Serum 46 | 13,691 | Positive | >1:40/>1:960 | 3,07% | Positive | < 1:10 |